特立列汀產品是Teneligliptin is a potent DPP-4?(dipeptidylpeptidase-4) inhibitor, that competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with?IC??s of approximately 1 nM. Useful drug for treatment of type 2 diabetes mellitus (T2DM).